EBRCZ · XBRL financial data
EBR Systems financial statements, every fiscal year
The same tables from 2 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (EBRCZ's year ends in late December)
| In thousands of dollars | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|
| Revenue | — | 1,617 |
| Cost of revenue | — | 1,127 |
| Gross profit | — | 490 |
| Research and development | 27,065 | 23,940 |
| General and administrative | 11,254 | 22,637 |
| Total operating expenses | 38,319 | 46,577 |
| Operating income (loss) | (38,319) | (46,087) |
| Interest income | 3,181 | 2,707 |
| Interest expense | 6,030 | 5,644 |
| Other income (expense) | 361 | 304 |
| Income tax expense (benefit) | 2 | 2 |
| Net income (loss) | (40,798) | (48,758) |
| Earnings per share, basic USD per share | (0.13) | (0.12) |
| Earnings per share, diluted USD per share | (0.13) | (0.12) |
| Weighted average shares, basic thousands of shares | 324,995 | 417,327 |
| Weighted average shares, diluted thousands of shares | 324,995 | 417,327 |
Balance sheet
CSVFiscal years (EBRCZ's year ends in late December)
| In thousands of dollars | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|
| Cash and cash equivalents | 6,918 | 5,794 |
| Marketable securities | 53,746 | 47,395 |
| Marketable securities, non-current | 5,304 | 1,011 |
| Inventory | 2,843 | 13,789 |
| Total current assets | 64,466 | 73,111 |
| Property and equipment, net | 795 | 5,477 |
| Right-of-use asset | 929 | 12,613 |
| Total assets | 73,559 | 97,226 |
| Accounts payable | 3,247 | 7,049 |
| Total current liabilities | 8,328 | 14,048 |
| Lease liability, non-current | 575 | 16,520 |
| Total liabilities | 49,204 | 71,638 |
| Accumulated deficit | (353,458) | (402,216) |
| Total stockholders' equity | 24,356 | 25,588 |
| Total liabilities and equity | 73,559 | 97,226 |
| Common shares outstanding (cover page) thousands of shares | 372,851 | 450,436 |
Cash flows
CSVFiscal years (EBRCZ's year ends in late December)
| In thousands of dollars | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|
| Net income (loss) | (40,798) | (48,758) |
| Stock-based compensation | 1,742 | 3,051 |
| Depreciation and amortization | 587 | 403 |
| Net cash from operating activities | (41,230) | (53,192) |
| Purchases of property and equipment | 273 | 3,683 |
| Net cash from investing activities | 1,113 | 7,836 |
| Proceeds from issuing common stock | 34,022 | 48,828 |
| Net cash from financing activities | 32,484 | 46,829 |
| Net change in cash | (7,661) | 1,480 |
Compare with peers
SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| EBR Systems | 59,350 | 2,637 | (17,194)* | 75.3M | 5.0 quarters | 10-QJun 30, 2026 |
| Orthopediatrics | 17,141 | 72,661 | 4,506* | 26.1M | — | 10-QSep 30, 2026 |
| Outset Medical | 35,005 | 31,635 | (9,635)* | 18.8M | 15.3 quarters | 10-QJun 30, 2026 |
| ClearPoint Neuro | 46,184 | 12,075 | (20,100) | 32.1M | 6.6 quarters | 10-QSep 30, 2026 |
| Butterfly Network | 122,301 | 32,598 | (2,266)* | not reported | 10.3 quarters | 10-QSep 30, 2026 |
| Pulse Biosciences | 101,620 | 434 | (18,709)* | 71.3M | 5.4 quarters | 10-QJun 30, 2026 |
| NeuroPace | 12,538 | 22,826 | (3,903)* | 34.3M | 13.2 quarters | 10-QJun 30, 2026 |
| Ceribell | 41,989 | 29,341 | (13,078)* | 38.8M | 7.8 quarters | 10-QSep 30, 2026 |
| Delcath Systems | 47,521 | 29,133 | 5,712* | 34.7M | — | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.